Upcoming Events
East Lansing, Michigan (August 17, 2012): Retia Medical, LLC, announced today that it has received a $151,000 Small Business Innovative Research (SBIR) Phase I award from the National Institute of Health. The funding represents an initial investment from the NIH to demonstrate the clinical performance of Retia’s breakthrough less-invasive technology to monitor cardiac output. Cardiac […]
Read MoreCardiovascular Signal Processing Technology Exclusively Licensed from Michigan State University -Enables Monitoring of More Than 18 Million High-Risk Patients Worldwide -Shows Superior Accuracy When Patients Are Unstable EAST LANSING, Mich., Aug. 16, 2012 — Retia Medical, a medical device company pioneering the field of cardiovascular signal processing for patient monitoring, announced it had raised $7 Million in Series […]
Read More